Skip to main content
Clinical Trials/CTRI/2023/11/060183
CTRI/2023/11/060183RecruitingNot Applicable

Clinical evaluation of targeted airway ultrasound in determining difficult video laryngoscopy.

Homibhabha cancer hospital and research center1 site in 1 country435 target enrollmentStarted: December 2, 2023Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
435
Locations
1
Primary Endpoint
To evaluate the efficacy of airway ultrasound parameters over conventional airway assessment in predicting difficult airway using video laryngoscope as endpoint of intervention

Study Overview

Brief Summary

This study aims to evaluate focused airway ultrasound ability to assess the difficult airway prediction, and its valuation using video laryngoscopy as the final correlation in the determination of airway difficulty assessment efficacy.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • All adult patients(> 18 years) planned for elective surgery under neuromuscular relaxation with orotracheal intubation.

Exclusion Criteria

  • Restricted mouth opening <3cm Nasotracheal intubation Prior irradiation to the head and neck region BMI >35kgm-2 Extra axial mass in the neck and/or demonstrated intraluminal airway obstruction including tongue and laryngeal malignancies.
  • Physiologically difficult airway Suspected or proven airway hemorrhage Room air saturation < 95% at room air Inability and Unwillingness to provide informed consent.
  • Patients at risk of aspiration of gastric contents.

Outcomes

Primary Outcomes

To evaluate the efficacy of airway ultrasound parameters over conventional airway assessment in predicting difficult airway using video laryngoscope as endpoint of intervention

Time Frame: At baseline after intubation.

Secondary Outcomes

  • comparison of clinical predictors over airway ultrasound(1 year)

Investigators

Sponsor
Homibhabha cancer hospital and research center
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

DR KALYANI MANASA RAPETI

Homi Bhabha Cancer Hospital and Research Center

Study Sites (1)

Loading locations...

Similar Trials